Sterin-Borda L, Perez Leiros C, Wald M, Cremaschi G, Borda E
Centro de Estudios Farmacológicos y de Principios Naturales, Buenos Aires, Argentina.
Clin Exp Immunol. 1988 Dec;74(3):349-54.
Evidence accumulated over the last decade concerning human and experimental models suggests that an immunopathological mechanism may be involved in the pathogenesis of chronic Chagas' disease. In this paper we demonstrate the existence of two different circulating IgG in chagasic patients which bind with myocardial beta 1 and spleen cell beta 2 adrenoceptors, acting as non-competitive inhibitors. Both chagasic IgG against beta 1 and beta 2 adrenoceptor increased intracellular levels of cAMP that could be blocked by specific beta 1 and beta 2 adrenoceptor antagonists. The specificity for beta 1 and beta 2 adrenoceptors and the independence of other tissue reactive antibodies was demonstrated by IgG absorption with turkey red blood cell (TRBC), human lymphocytes (HL) or guinea pig red blood cells (GPRBC). The F(ab')2 fraction acted similarly. This supports the specificity of beta 1 and beta 2 adrenoceptors to the chagasic IgG and the independence of the other tissue reactive antibodies, such as EVI system. The probable pathogenic role of both beta 1 and beta 2 adrenergic chagasic antibody is discussed.
过去十年间,有关人类和实验模型积累的证据表明,免疫病理机制可能参与慢性恰加斯病的发病过程。在本文中,我们证明了恰加斯病患者体内存在两种不同的循环IgG,它们与心肌β1和脾细胞β2肾上腺素能受体结合,起到非竞争性抑制剂的作用。针对β1和β2肾上腺素能受体的恰加斯病IgG均可增加细胞内cAMP水平,而这可被特异性β1和β2肾上腺素能受体拮抗剂阻断。通过用鸡血红细胞(TRBC)、人淋巴细胞(HL)或豚鼠红细胞(GPRBC)吸收IgG,证实了其对β1和β2肾上腺素能受体的特异性以及其他组织反应性抗体的独立性。F(ab')2片段也有类似作用。这支持了β1和β2肾上腺素能受体对恰加斯病IgG的特异性以及其他组织反应性抗体(如EVI系统)的独立性。本文还讨论了β1和β2肾上腺素能恰加斯病抗体可能的致病作用。